Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary Adenocarcinoma

BACKGROUND: Plasminogen activator inhibitor type 1 (PAI-1), an important regulator of plasminogen activator system which controls degradation of extracellular membrane and progression of tumor cells, and PAI-1 gene polymorphic variants have been known as the prognostic biomarkers of non-small cell l...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ju Eun, Park, Moo Suk, Kim, Eun Young, Jung, Ji Ye, Kang, Young Ae, Kim, Young Sam, Kim, Se Kyu, Shim, Hyo Sup, Cho, Byoung Chul, Chang, Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833934/
https://www.ncbi.nlm.nih.gov/pubmed/24265642
http://dx.doi.org/10.4046/trd.2013.75.4.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833934/
https://www.ncbi.nlm.nih.gov/pubmed/24265642
http://dx.doi.org/10.4046/trd.2013.75.4.140

Ejemplares similares